A phase II study of sequential carboplatin (C), paclitaxel (P) and topetecan (T) in patients with previously untreated advanced ovarian cancer

被引：0
|
作者：
Agarwal, R
Seckl, MJ
Nelstrop, A
Rustin, GJS
机构：
[1] Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England
[2] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P315
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
    A E Guppy
    A E Nelstrop
    T Foster
    R Agarwal
    M J Seckl
    G J S Rustin
    British Journal of Cancer, 2004, 90 : 810 - 814
  • [2] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
    Guppy, AE
    Nelstrop, AE
    Foster, T
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2004, 90 (04) : 810 - 814
  • [3] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer.
    Guppy, AE
    Nelstrop, A
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2002, 86 : S44 - S44
  • [4] Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC
    Gerber, David E.
    Swanson, Paul
    Lopez-Chavez, Ariel
    Wong, Lucas
    Dowlati, Afshin
    Pennell, Nathan A.
    Cronier, Damien M.
    Qin, Amy
    Ilaria, Robert, Jr.
    Cosaert, Jan
    Shahir, Ashwin
    Baggstrom, Maria Q.
    LUNG CANCER, 2017, 111 : 108 - 115
  • [5] Phase I study of repetitive high-dose topotecan (T) carboplatin (C) and paclitaxel (P) in previously untreated ovarian cancer
    Rischin, D
    Prince, M
    Quinn, M
    Allen, D
    Planner, R
    Davison, J
    Gates, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S238 - S238
  • [6] A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer
    Adams, M
    Mort, D
    Coleman, R
    Wiliams, L
    Evans, A
    Thompson, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 496 - 496
  • [7] Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer
    Gordon, AN
    Asmar, L
    Messing, MJ
    Street, DG
    Pippitt, CH
    Bailey, CL
    Savage, J
    Young, JA
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 533 - 539
  • [8] Carboplatin plus paclitaxel and sequential radiation followed by consolidation carboplatin and paclitaxel in patients with previously untreated locally advanced NSCLC - A Hoosier Oncology Group (HOG) phase II study
    Bhatia, S
    Hanna, N
    Ansari, R
    Einhorn, L
    Sandler, A
    LUNG CANCER, 2002, 38 (01) : 85 - 89
  • [9] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Andre Michel Kallab
    Yasolatha Nalamolu
    Paul Maclyn Dainer
    Anand Prasad Jillella
    Medical Oncology, 2005, 22 : 145 - 151
  • [10] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Kallab, AM
    Nalamolu, Y
    Dainer, PM
    Jillella, AP
    MEDICAL ONCOLOGY, 2005, 22 (02) : 145 - 151
12345